Clinical Trial Update: A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating cisplatin and radiation in combination with sorafenib for cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Platinol (cisplatin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer of the Cervix | Phase 1, Phase 2 | Status: COMPLETED